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Solution X-ray scattering experiments have been performed with apo- and hobo-aspirate amino~ransferase 
to detect he ~onforma~ona~ change, demonstrated bya variety of techniques, induced by the binding of 
the coenzyme pyridoxaf 5’-phosphate o apoenzyme. The co~fo~ational change could not, in fact, be 
observed by solution X-ray scattering. This suggests hat there is no major modification of the overall 
shape of the enzyme upon coenzyme binding, although there are likely to be variations in the 
protein-solvent interactions. An accurate value of the radius of gyration, 29.0 + 0.5 A has been 
determined. 
Aspartate aminotransfernse Coenzyme binding Solution X-ray scattering 
Synchrotron radiation 
Aspartate aminotransferase (AAT) (L- 
aspartate: 2-oxoglutarate aminotransferas~, EC 
2.6.1.1.), a key enzyme of nitrogen metabolism, 
catalyzes the reversible transfer of an amino group 
from L-aspartate or L-glutamate to the cy- 
ketoacids 2-oxoglutarate or oxaloacetate. Distinct 
cytosolic and mitochondrial isoenzymes have been 
found in animal tissues. The pig heart cytosolic en- 
zyme (which has been the most extensively studied) 
is n dimer composed of identical subunits contain- 
ing 412 amino acids, whose sequence has been 
determined [l]* Analysis of the three-djmension~ 
structure of the enzyme is in progress [2,3]. This 
structure has been found to be closely related to 
that of other AAT, the structure of which is more 
advanced: the three-dimensional structure af the 
chicken heart mitochondrjal enzyme is known at 
2.8 14 resolution [4] and that of the chicken heart 
cytosolic enzyme at 3.2 A resolution f5,6]. The 
crystalline enzyme is catalytically competent f7] 
and AAT crystals are being used to search for reac- 
tion intermediates [7- 101 . 
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~onformatio~al changes between apo- and 
holoAAT are well known. Several different ex- 
perimental approaches, mainly performed on 
cytosolic enzyme, include: stability toward 
denaturing factors [ 1 l-141 and dilution [ 151, op- 
tical rotatory dispersion 1161, fluorescence spec- 
troscopy [17], hydrogen-deuterium exchange [18]( 
stopped flow kinetics 1191, sedimentation velocity 
measurements f IS] and preliminary experiments 
using quasi-elastic light scattering I2OJ. These 
studies suggest hat an important conformationa~ 
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change is induced by coenzyme binding. However, 
crystallographic analysis of both forms of the 
chicken mitochondrial AAT revealed no signifi- 
cant difference [4], except for some local changes 
located in the active site region [21]. These studies 
were performed in the presence of Pi. Kinetic ex- 
periments of the competition between PLP and 
phosphate for the binding to apoenzyme now sug- 
gest that phosphate alone induces a conforma- 
tional change in the protein when bound to the co- 
enzyme binding site [22]. Thus, if the changes in- 
duced by PLP and phosphate are similar, X-ray 
diffraction would have failed to detect hem. Also, 
it was not excluded that the behavior of AAT 
could be different in the crystal and in solution. 
A-’ <s< 1.4 x 10e2 A-’ (s = sin 8/r) were record- 
ed with a sample to detector distance of 850 mm. 
Higher angle data, 4 x low3 A-‘<s<4 x 10m2 
A-‘, were recorded with a sample-to-detector 
distance of 640 mm. Absolute scale measurements 
were obtained with reference to scattering from a 
pre-calibrated black carbon sample. After solvent 
subtraction, the data were corrected for collima- 
tion distortions as in [31]. 
To clarify this point, solution X-ray scattering 
experiments (SXRS) were performed with both 
apo and holoenzyme from pig heart cytosol 
(without phosphate). It turned out that no confor- 
mational change could be detected. This finding is 
discussed in reference to previous studies. 
The samples were contained in quartz capillary 
tubes =l mm diam. About 20 ~1 were used for 
each experiment. All samples were prepared in 
0.05 M triethanolamine-HCl buffer (pH 8.3). The 
solutions were concentrated by ultrafiltration on 
ultragaines UH 100/25 (Schleicher and Schull) and 
centrifuged before use. Samples were 7-20 mg/ml 
for low angle experiments. Exposure was for 
5 min. Samples were 20-100 mg/ml for higher 
angle experiments and exposure varied from lo-20 
min. The enzymatic activity was found to be iden- 
tical before and after the experiments. 
2. MATERIALS AND METHODS 3. RESULTS 
2.1. Enzyme 
Holoaspartate aminotransferase (a-form) was 
prepared from pig heart cytosol according to [23] 
as modified [24]. The apoenzyme, free of 
phosphate, was prepared according to [25] as in 
[26]. Enzyme concentrations were determined by 
absorbance measurements [ 171. Transaminase ac- 
tivity was measured according to [27] as in [26]. 
For the analysis of low angle data, we made use 
of Guinier plots, namely the logarithm of intensity 
vs 3. Such plots yield straigh lines whose slope is 
proportional to the square of the radius of gyra- 
tion of the particle and whose extrapolation to the 
2.2. Solution X-ray scattering experiments 
The experiments were performed with the small- 
angle camera at the Synchrotron Radiation 
Laboratory (LURE, Orsay). The camera has been 
described in [28]. Briefly, X-rays were monochro- 
mated using the (111) reflection of a bent ger- 
manium crystal [29]. The wavelength was 1.54 A 
and the beam cross-section at focus was 
1 mm x 0.4 mm. The synchrotron ring was 
operated at I .72 GeV and 100-300 mA. The detec- 
tor was a linear position-sensitive detector with 
delay line [30] (as modified by M. Lemonnier). The 
data were recorded in a Tracer TN 1710 






The data were recorded in two different series of 
experiments. Low angle data, 1.4 x 1o-3 
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Fig. 1. Examples of Guinier plots for AAT: (a) holoen- 
zyme, 15.2 mg/ml; (b) holoenzyme, 9.0 mg/ml; (c) 
apoenzyme, 9.8 mg/ml. The intensities are given in ar- 
bitrary units. They are corrected for background and 
detector response but otherwise are unsmoothed and un- 
corrected for collimation distortions. Note that these 
plots are linear over an extended range. 
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origin permits the determination of the partick M, that the enzyme is not contaminated with ag- 
[32]. Typical curves are shown in fig. 1. gregates in solution. 
We found M; 97 000 + gOO0 in excellent agree- 
ment with the value calculated from the primary 
sequence: 93 000 [l]. This result, together with the 
observed linearity of the Guinier plots, indicates 
The variation of the radius of gyration as a func- 
tion of concentration, for both apo- and holo- 
enzyme, is shown in fig. 2. It is clear from the 
figure that no significant difference in the radius of 
gyration can be detected between holo- and apo- 
enzyme. The value extrapolated to zero concentra- 
tion from the whole of the experimental data is 
equal to 29.0 x OS A. 
c fmgrmi) 
Fig. 2. Variation of the radius of oration as a function 
of concentration for the (ef apo- and (0) hoIoeu2yme. 
The values are corrected for collimation distortions. 
Given the quality of the data (fig. I), the error bars 
derive mainly from the uncertainty (a 2010) in the coeffi- 
cient of the background subtracted, 
Fig. 3. Example of extended scattering curves of (upper) 
holo- and (Lower) apoenzyme. The intensities are given 
in arbitrary units and are vertically shifted to facilitate 
comparjson. The data are uncorrected for background 
or detector response, They were recorded under exactly 
the same concentration conditions for both apo- and 
ho~oenzyme (43 mg/mL). 
Experiments at higher concentration were per- 
formed in the attempt to detect a possible dif- 
ference between apo- and hoIoenzyme in the higher 
angle part of the scattering curves. Scattering 
curves, under identical concentration conditions, 
were also fourrd to be similar (e.g., fig. 3). Conse- 
quently, the data were not analyzed further. 
4. DISCUSSION 
From the X-ray scattering study [33], a value of 
32.6 + 0.9 A was reported for the radius of gyra- 
tion, definitely higher than the value we have 
measured (29.0 + OS A). Possible explanations 
for such a discrepancy are the lower accuracy in 
f33] or the presence of a small amount of ag- 
gregates, or, more simply, that the preparation in 
[33] was a mixture of several subforms which are 
known to have different sugar contents [24,34,35]. 
Here, the good agreement obtained for the Mt and 
perfect linearity of the Guinier plots argues for the 
absence of aggregates; moreover, the pure E-form 
(free of sugars) of AAT was used. 
The results obtained here can also be compared 
to the crystallographic data. According to them, 
the AAT molecule can be approximated at tow 
resolution by an ellipsoid of dimensions 
105 x 60 x 50 A [4]. The calculated radius of gyra- 
tion of such an ellipsoid is 29.3 A which compares 
well with our experimental value. A sphere occupy- 
ing the same volume would have a radius of gyra- 
tion of 26.3 A, 
The fact that we did not detect conformational 
changes induced by the binding of the coenzyme 
does not mean that they do not occur. This result 
suggests that conformational changes determined 
by spectroscopic experiments are local and do not 
correspond to large rearrangements of the mole- 
cule. They probably reflect the changes around the 
active site demonstrated by crystallographic 
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analysis. Such local changes would not be detected 
in these experiments. However, other changes 
could also occur, that would remain unnoticed 
with SXRS. For instance, as the coenzyme binding 
site possesses everal charged groups, removal of 
the coenzyme could lead to differences in pro- 
tein-solvent interactions. A difference in the inter- 
nal motions of the molecule could also occur, as 
suggested by the lower stability of the apoenzyme 
toward denaturation [ 1 l-141, the facilitated 
dissociation of apoenzyme into subunits upon dilu- 
tion [15,36] and by hydrogen-deuterium exchange 
experiments [181. 
Thus, we are led to conclude, in agreement with 
diffraction experiments, that the conformational 
change between the apo- and holoenzyme does not 
correspond to a major modification of the overall 
shape of the enzyme. However, this conforma- 
tional change can involve local changes and, in 
solution, may be associated with modifications of 
the protein-solvent interactions and/or with larger 
structural fluctuations of the apoenzyme com- 
pared to holoenzyme. 
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